4.1 Article

Frusemide aids diagnostic interpretation of 68Ga-PSMA positron emission tomography/CT in men with prostate cancer

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging

Thorsten Derlin et al.

EUROPEAN RADIOLOGY (2016)

Review Urology & Nephrology

Current use of PSMA - PET in prostate cancer management

Tobias Maurer et al.

NATURE REVIEWS UROLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

Matthias Eiber et al.

JOURNAL OF NUCLEAR MEDICINE (2015)

Article Gastroenterology & Hepatology

Ga-68-PSMA PET/MR with multimodality image analysis for primary prostate cancer

Matthias Eiber et al.

ABDOMINAL IMAGING (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

Ali Afshar-Oromieh et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

Ali Afshar-Oromieh et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

A. Afshar-Oromieh et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)